$0.30
(Market cap
$6,965 Mln
Recently Viewed
Clear AllMarket cap
$6,965 Mln
Revenue (TTM)
$1,313 Mln
P/E Ratio
33.5
P/B Ratio
3.3
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
Industry P/E
--
EV/EBITDA
15.6
Debt to Equity
0.5
Book Value
$--
EPS
$--
Face value
--
Shares outstanding
84,478,406
CFO
$1,104.25 Mln
EBITDA
$1,281.24 Mln
Net Profit
$208.19 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
HealthEquity (HQY)
| -11.1 | -1.2 | -1.7 | -3.5 | 15.1 | 1.3 | 12.2 |
|
BSE Sensex*
| -9.2 | 6.9 | -6.5 | -4.2 | 8.0 | 9.1 | 11.6 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
HealthEquity (HQY)
| -4.5 | 44.3 | 7.6 | 39.3 | -36.5 | -5.9 | 24.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
HealthEquity (HQY)
|
81.5 | 6,965.2 | 1,313.4 | 215.2 | 24.6 | 10.2 | 33.5 | 3.3 |
| 24.7 | 3,259.1 | 1,177.3 | 101.3 | 8.8 | -198.6 | 40.6 | 31.8 | |
| 22.7 | 2,640.0 | 738.2 | -131.3 | -18.9 | -23.9 | -- | 4.2 | |
| 21.9 | 3,659.5 | 956.8 | -56.0 | -7.2 | -6.3 | -- | 3.7 | |
| 17.5 | 2,027.6 | 594.8 | 5.2 | 3.2 | 0.5 | 353.6 | 1.9 | |
| 10.0 | 3,855.0 | 709.0 | -679.4 | -12.9 | 466.8 | -- | 19.8 | |
| 11.6 | 6,737.5 | 1,071.4 | -270.1 | -28.1 | -42.9 | -- | 1.0 | |
| 14.7 | 4,736.7 | 1,001.3 | -450.7 | -32.5 | -29 | -- | 3.5 | |
| 5.0 | 1,204.5 | 857.2 | 22.9 | 6.7 | 3.8 | 53.8 | 2.2 | |
| 10.4 | 5,286.4 | 1,610.6 | 282.3 | 3.6 | 14.4 | 19.4 | 2.5 |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. It offers health savings accounts (HAS); investment platform; online-only automated investment advisory services through Advisor, a... Web-based tool. The company also provides flexible spending accounts (FSA) for health and dependent care; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. In addition, the company offers HSA and FSA members with access to certain healthcare products, programs, and services through its marketplace. It serves clients through a direct sales force; and brokers and advisors, a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah. Read more
President, CEO & Director
Mr. Jon Kessler
President, CEO & Director
Mr. Jon Kessler
Headquarters
Draper, UT
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of HealthEquity Inc (HQY) is $81.48 (NASDAQ) as of 29-Apr-2026 16:00 EDT. HealthEquity Inc (HQY) has given a return of 15.09% in the last 3 years.
The P/E ratio of HealthEquity Inc (HQY) is 33.52 times as on 24-Apr-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2026
|
--
|
--
|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
--
|
--
|
The 52-week high and low of HealthEquity Inc (HQY) are Rs 116.65 and Rs 72.76 as of 30-Apr-2026.
HealthEquity Inc (HQY) has a market capitalisation of $ 6,965 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in HealthEquity Inc (HQY), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.